Simultaneous inhibition of two proteins may be a new strategy for tackling triple-neg

[News]

Researchers at the Centre for Genomic Regulation and Vall d'Hebron Institute of Oncology have shown that the simultaneous inhibition of two different proteins may represent a new strategy for tackling triple-negative breast cancer, the most aggressive and drug-resistant form of breast cancer.

More... (https://www.news-medical.net/news/20231108/Simultaneous-inhibition-of-two-proteins-may-be-a-new-strategy-for-tackling-triple-negative-breast-cancer.aspx)